Shenghui Integration: Subsidiary Wins Bid for Project Worth Approximately 223 Million Yuan
Shenghui Integration's Indonesian subsidiary has secured a significant construction project valued at approximately 223 million RMB. This project involves the development of a shoe sole and footwear production facility. Separately, a subsidiary of Sunshine Nuohe has received approval for clinical trials for its STC009 injection, intended for treating secondary hyperparathyroidism. AI
IMPACT This cluster reports on a construction project win and a drug trial approval, with no direct impact on AI operators.